Fig. 1
From: Systemic PCSK9 elevation characterises autoimmune liver disease across sexes
PCSK9 in the serum of patients and controls: (a) Serum PCSK9 levels in controls, patients with primary sclerosing cholangitis (PSC), patients with primary biliary cholangitis (PBC) and patients with autoimmune hepatitis (AIH). (b) Serum PCSK9 levels in female patients and controls. (c) Serum PCSK9 levels in male patients and controls. (d) PCSK9 serum levels in male and female patients with PSC. * p < 0.05, ** p < 0.01, *** p < 0.001.
